Nanomedicine: Application areas and development prospects

International Journal of Molecular Sciences

Volumn 12, Issue 5, 2011, Pages 3303-3321

  Boulaiz, Houria ^a   Alvarez, Pablo J ^a   Ramirez, Alberto ^a   Marchal, Juan A ^a   Prados, Jose ^a   Rodríguez Serrano, Fernando ^a   Perán, Macarena ^b   Melguizo, Consolación ^a   Aranega, Antonia ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF JAÉN   (Spain)

Author keywords

Drug delivery; Early diagnosis; Nanomedicine; Nanostructures

Indexed keywords

CAMPTOTHECIN; CANCER VACCINE; CISPLATIN; CLOBETASOL PROPIONATE; CLOTRIMAZOLE; DENDRIMER; DIETHYLTOLUAMIDE; DOXORUBICIN; FLUOROURACIL; GOLD NANOPARTICLE; IBUPROFEN; INSULIN; IRINOTECAN; ISOTRETINOIN; KETOCONAZOLE; LIPOSOME; MIFEPRISTONE; NANOCARRIER; NANOMATERIAL; OXYBENZONE; PILOCARPINE; QUANTUM DOT; RETINOID; RETINOL; SOLID LIPID NANOPARTICLE; TAMOXIFEN CITRATE; TITANIUM DIOXIDE; TRIPTOLIDE; UBIDECARENONE; UNINDEXED DRUG; GOLD; METAL NANOPARTICLE; MICELLE;

BIOCHIP; BIOSENSOR; DIAGNOSTIC TEST; DNA DETERMINATION; DRUG DELIVERY SYSTEM; DRUG SCREENING; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MICROARRAY ANALYSIS; MOLECULAR IMAGING; NANOEMULSION; NANOMEDICINE; REGENERATIVE MEDICINE; REVIEW; CHEMISTRY; GENETIC PROCEDURES; LAB ON A CHIP; PROCEDURES; TRENDS;

BIOSENSING TECHNIQUES; DENDRIMERS; DRUG DELIVERY SYSTEMS; GOLD; LAB-ON-A-CHIP DEVICES; LIPOSOMES; METAL NANOPARTICLES; MICELLES; NANOMEDICINE; NANOSTRUCTURES; QUANTUM DOTS; REGENERATIVE MEDICINE;

EID: 79957857652     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12053303     Document Type: Review

References (76)

1. Appenzeller, T. The man who dared to think small. Science 1991, 254, 1300-1301.
2. Kang, Y.S.; Risbud, S.; Rabolt, J.F.; Stroeve, P. Synthesis and characterization of nanometer-size Fe3O4 and g-Fe2O3 particles. Chem. Mater. 1996, 8, 2209-2211.
3. Pankhurst, Q.A.; Connoly, J.; Jones, S.K. Applications of magnetic nanoparticles in biomedicine. J. Phys. D. Appl. Phys. 2003, 36, 167.
4. Dobson, J. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther. 2006, 13, 283-287.
5. Rudge, S.; Peterson, C.; Vessely, C.; Koda, J.; Stevens, S.; Catterall, L. Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC). J. Control. Release 2001, 74, 335-340.
6. Mody, V.V.; Siwale, R.; Singh, A.; Mody, H.R. Introduction to metallic nanoparticles. J. Pharm. Bioallied. Sci. 2010, 2, 282-289.
7. Zhang, L.; Gu, F.X.; Chan, J.M.; Wang, A.Z.; Langer, R.S.; Farokhzad, O.C. Nanoparticles in medicine: Therapeutic applications and developments. Clin. Pharmacol. Ther. 2008, 83, 761-769.
8. Surendiran, A.; Sandhiya, S.; Pradhan, S.C.; Adithan, C. Novel applications of nanotechnology in medicine. Indian J. Med. Res. 2009, 130, 689-701.
9. Zarbin, M.A.; Montemagno, C.; Leary, J.F.; Ritch, R. Nanotechnology in ophthalmology. Can. J. Ophthalmol. 2010, 45, 457-476.
10. Jain, K.K. Nanotechnology in clinical laboratory diagnostics. Clin. Chim. Acta 2005, 358, 37-54.
11. Jain, K.K. Nanodiagnostics: Application of nanotechnology in molecular diagnostics. Expert Rev. Mol. Diagn. 2003, 3, 153-161.
12. Singh, R.P.; Oh, B.K.; Ch, J.W. Application of peptide nucleic acid towards development of nanobiosensor arrays. Bioelectrochemisty 2010, 79, 153-161.
13. European Technology Platform on Nanomedicine. Nanotechnology for Health. Vision Paper and Basis for a Strategic Research Agenda for Nanomedicine. Eur. Comm. 2005, 1, 1-39.
14. Debouck, C.; Goodfellow, P.N. DNA microarrays in drug discovery and development. Nat. Genet. 1999, 21, 48-50.
15. Cole, K.A.; Krizman, D.B.; Emmert-Buck, M.R. Chuaqui, R.F.; Bonner, R.F.; Best, C.J. The genetics of cancer: A 3D model. Nat. Genet.1999, 21, 38-41.
16. Gerhold, D.L.; Jensen, R.V.; Gullans, S.R. Better therapeutics through microarrays. Nat. Genet. 2002, 32, 547-551.
17. Heller, R.A.; Schena, M.; Chai, A.; Shalon, D.; Bedilion, T.; Gilmore, J.; Woolley, D.E.; Davis, R.W. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc. Natl. Acad. Sci. USA 1997, 94, 2150-2155.
18. McCaffrey, T.A.; Fu, C.; Du, B.; Eksinar, S.; Kent, K.C.; Bush, H., Jr.; Kreiger, K.; Rosengart, T.; Cybulsky, M.I.; Silverman, E.S.; Collins, T. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J. Clin. Invest. 2000, 105, 653-662.
19. Perou, C.M.; Jeffrey, S.S.; Van de Rijn, M.; Rees, C.A.; Eisen, M.B.; Ross, D.T; Pergamenschikov, A.; Williams, C.F.; Zhu, S.X.; Lee, J.C.; Lashkari, D.; Shalon, D.; Brown, P.O.; Botstein, D. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. USA 1999, 96, 9212-9217.
20. Perou, C.M.; Sørlie, T.; Eisen, M.B.; Rijn, M.; Jeffrey, S.S.; Rees, C.A.; Pollack, J.R.; Ross, D.T.; Johnsen, H.; Akslen, L.A.; Fluge, O.; Pergamenschikov, A.; Williams, C.; Zhu, S.X.; Lønning, P.E.; Børresen-Dale, A.L.; Brown, P.O.; Botstein, D. Molecular portraits of breast tumours. Nature 2000, 406, 747-752.
21. Alon, U.; Barkai, N.; Notterman, D.A.; Gish, K.; Ybarra, S.; Mack, D.; Levine, A.J. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 1999, 96, 6745-6750.
22. Kaminski, N.; Allard, J.D.; Pittet, J.F.; Zuo, F.; Griffiths, M.J.; Morris, D.; Huang, X.; Sheppard, D.; Heller, R.A. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc. Natl. Acad. Sci. USA 2000, 97, 1778-1783.
23. Stoughton, R.B. Applications of DNA microarrays in biology. Annu. Rev. Biochem. 2005, 74, 53-82.
24. Plomin, R.; Schalkwyk, L.C. Microarrays. Dev. Sci. 2007, 10, 19-23.
25. Schulze, A.; Downward, J. Navigating gene expression using microarrays-a technology review. Nat. Cell Biol. 2001, 3, 190-195.
26. Kennedy, G.C.; Matsuzaki, H.; Dong, S.; Liu, W.M.; Huang, J.; Liu, G.; Su, X.; Cao, M.; Chen, W.; Zhang, J.; Liu, W.; Yang, G.; Di, X.; Ryder, T.; He, Z.; Surti, U.; Phillips, M.S.; Boyce-Jacino, M.T.; Fodor, S.P.; Jones, K.W. Large-scale genotyping of complex DNA. Nat. Biotechnol. 2003, 21, 1233-1237.
27. Ulger, C.; Toruner, G.A.; Alkan, M.; Mohammed, M.; Damani, S.; Kang, J.; Galante, A.; Aviv, H.; Soteropoulos, P.; Tolias, P.P.; Schwalb, M.N.; Dermody, J.J. Comprehensive genome-wide comparison of DNA and RNA level scan using microarray technology for identification of candidate cancer-related genes in the HL-60 cell line. Cancer Genet. Cytogenet. 2003, 147, 28-35.
28. MacBeath, G. Protein microarrays and proteomics. Nat. Genet. 2002, 32, 526-532.
29. Braunschweig, T.; Chung, J.Y.; Hewitt, S.M. Tissue microarrays: Bridging the gap between research and the clinic. Expert Rev. Proteomics 2005, 2, 325-336.
30. Clarke, P.A.; Poele, R.; Wooster, R.; Workman, P. Gene expression microarray analysis in cancer biology, pharmacology, and drug development: Progress and potential. Biochem. Pharmacol. 2001, 62, 1311-1336.
31. Jayapal, M.; Melendez, J.A. DNA microarray technology for target identification and validation. Clin. Exp. Pharmacol. Physiol. 2006, 33, 496-503.
32. Ghallab, Y.H.; Badawy, W. Lab-on-a-Chip: Techniques, Circuits, and Biomedical Applications; Artech House: Norwood, MA, USA, 2010; pp. 1-220.
33. Kim, J.; Byun, D.; Mauk, M.G.; Bau, H.H. A disposable, self-contained PCR chip. Lab Chip 2009, 9, 606-612.
34. Lab-on-a-Chip: Miniaturized Systems for (Bio)Chemical Analysis and Synthesis, 2nd ed.; Oosterbroek, E., Van den Berg, A., Eds.; Elsevier Science: Amsterdam, The Netherlands, 2003; pp. 1-402.
35. Stybayeva, G.; Mudanyali, O.; Seo, S.; Silangcruz, J.; Macal, M.; Ramanculov, E.; Dandekar, S.; Erlinger, A.; Ozcan, A.; Revzin, A. Lensfree holographic imaging of antibody microarrays for high-throughput detection of Leukocyte numbers and function. Anal. Chem. 2010, 82, 3736-3744.
36. Weissleder, R.; Pittet, M.J. Imaging in the era of molecular oncology. Nature 2008, 452, 580-589.
37. Wang, W.; Eddy, R.; Condeelis, J. The cofilin pathway in breast cancer invasion and metastasis. Nat. Rev. Cancer 2007, 7, 429-440.
38. Weissleder, R. Molecular imaging in cancer. Science 2006, 312, 1168-1171.
39. Jaffer, F.A.; Weissleder, R. Molecular imaging in the clinical arena. JAMA 2005, 293, 855-862.
40. Love, Z.; Wang, F.; Dennis, J.; Awadallah, A.; Salem, N.; Lin, Y.; Weisenberger, A.; Majewski, S.; Gerson, S.; Lee, Z. Imaging of mesenchymal stem cell transplant by bioluminescence and PET. J. Nucl. Med. 2007, 48, 2011-2020.
41. MacLaren, D.C.; Toyokuni, T.; Cherry, S.R.; Barrio, J.R; Phelps, M.E.; Herschman, H.R.; Gambhir, S.S. PET imaging of transgene expression. Biol. Psychiatry 2000, 48, 337-348.
42. Kraitchman, D.L.; Heldman, A.W.; Atalar, E.; Amado, L.C.; Martin, B.J; Pittenger, M.F.; Hare, J.M.; Bulte, J.W. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003, 107, 2290-2293.
43. Long, C.M.; Bulte, J.W. In vivo tracking of cellular therapeutics using magnetic resonance imaging. Expert Opin. Biol. Ther. 2009, 9, 293-306.
44. Kraitchman, D.L.; Bulte, J.W. Imaging of stem cells using MRI. Basic Res. Cardiol. 2008, 103, 105-113.
45. Kalish, H.; Arbab, A.S.; Miller, B.R.; Lewis, B.K.; Zywicke, H.A.; Bulte, J.W.; Bryant, L.H., Jr; Frank, J.A. Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: Relationship between relaxivities, electrostatic forces, and chemical composition. Magn. Reson. Med. 2003, 50, 275-282.
46. Muja, N.; Bulte, J. Magnetic resonance imaging of cells in experimental models. Prog. Nucl. Reson. Spectrosc. 2009, 55, 61-77.
47. Salata, O. Applications of nanoparticles in biology and medicine. J. Nanobiotechnol. 2004, 2, 3-9.
48. Bruchez, M.J.; Moronne, M.; Gin, P.; Weiss, S.; Alivisatos, A.P. Semiconductor nanocrystals as fluorescent biological labels. Science 1998, 281, 2013-2016.
49. Vizirianakis, I.S. Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes. Nanomedicine 2011, 7, 11-17.
50. Kawasaki, E.S.; Player, A. Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer. Nanomedicine 2005, 1, 101-109.
51. Veiseh, O.; Kievit, F.; Ellenbogen, R.G.; Zhang, M. Cancer Cell Invasion: Treatment and Monitoring Opportunities in Nanomedicine. Adv. Drug. Deliv. Rev. 2011, in press.
52. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J. Control. Release 2000, 65, 271-284.
53. Farokhzad, O.C.; Langer, R. Impact of nanotechnology on drug delivery. ACS Nano 2009, 3, 16-20.
54. Danhier, F.; Feron, O.; Préat, V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release 2010, 148, 135-146.
55. Tamilvanan, S. Formulation of multifunctional oil-in-water nanosized emulsions for active and passive targeting of drugs to otherwise inaccessible internal organs of the human body. Int. J. Pharm. 2009, 381, 62-76.
56. Maruyama, K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv. Drug. Deliv. Rev. 2011, in press.
57. Arias, J.L.; Gallardo, V.; Ruiz, M.A.; Delgado, A.V. Magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-Fluorouracil delivery systems for active targeting. Eur. J. Pharm. Biopharm. 2008, 69, 54-63.
58. Murphy, C.G.; Modi, S. HER2 breast cancer therapies: A review. Biologics Targets Ther. 2009, 3, 289-301.
59. Cirstoiu-Hapca, A.; Bossy-Nobs, L.; Buchegger, F.; Gurny, R.; Delie, F. Differential tumor cell targeting of anti-HER2 (Herceptin®) and anti-CD20 (Mabthera®) coupled nanoparticles. Int. J. Pharm. 2007, 331, 190-196.
60. Li, D.; Yu, H.; Huang, H.; Shen, F.; Wu, X.; Li, J.; Wang, J.; Cao, X.; Wang, Q.; Tang, G. FGF receptor-mediated gene delivery using ligands coupled to polyethylenimine. J. Biomater. Appl. 2007, 22, 163-180.
61. Song, S.; Liu, D.; Peng, J.; Sun, Y.; Li, Z.; Gu, J.; Xu, Y. Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo. Int. J. Pharm. 2008, 363, 155-161.
62. Serda, R.E.; Godin, B.; Blanco, E.; Chiappini, C.; Ferrari, M. Multi-stage delivery nano-particle systems for therapeutic applications. Biochim. Biophys. Acta 2011, 1810, 317-329.
63. Rangel-Yagui, C.O.; Pessoa, A.; Tavares, L.C. Micellar solubilization of drugs. J. Pharm. Pharm. Sci. 2005, 8, 147-163.
64. Sarker, D.K. Engineering of nanoemulsions for drug delivery. Curr. Drug Deliv. 2005, 2, 297-310.
65. Husseini, G.A.; PittMicelles, W.G. Nanoparticles for ultrasonic drug and gene delivery. Adv. Drug. Deliv. Rev. 2008, 60, 1137-1152.
66. Haley, B.; Frenkel, E. Nanoparticles for drug delivery in cancer treatment. Urol Oncol. 2008, 26, 57-64.
67. Hughes, G.A. Nanostructure-mediated drug delivery. Nanomedicine 2005, 1, 22-30.
68. Maruyama, K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv. Drug. Deliv. Rev. 2011, 63, 161-169.
69. Obata, Y.; Tajima, S.; Takeoka, S. Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo. J. Control. Release 2010, 142, 267-276.
70. Huang, S. Liposomes in ultrasonic drug and gene delivery. Adv. Drug. Deliv. Rev. 2008, 60, 1167-1176.
71. Koide, H.; Asai, T.; Hatanaka, K.; Akai, S.; Ishii, T.; Kenjo, E.; Ishida, T.; Kiwada, H.; Tsukada, H.; Oku, N. T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes. Int. J. Pharm. 2010, 392, 218-223.
72. Sakamoto, J.H.; Van de Ven, A.L.; Godin, B.; Blanco, E.; Serda, R.E.; Grattoni, A.; Ziemys, A.; Bouamrani, A.; Hu, T.; Ranganathan, S.I.; De Rosa, E.; Martinez, J.O.; Smid, C.A.; Buchanan, R.M.; Lee, S.; Srinivasan, S.; Landry, M.; Meyn, A.; Tasciotti, E.; Liu, X.; Decuzzi, P.; Ferrari, M. Enabling individualized therapy through nanotechnology. Pharmacol. Res. 2010, 62, 57-89.
73. Shekaran, A.; Garcia, A.J. Nanoscale engineering of extracellular matrix-mimetic bioadhesive surfaces and implants for tissue engineering. Biochim. Biophys. Acta 2011, 1810, 350-360.
74. Barnes, C.P.; Sell, S.A.; Boland, E.D.; Simpson, D.G.; Bowlin, G.L. Nanofiber technology: Designing the next generation of tissue engineering scaffolds. Adv. Drug. Deliv. Rev. 2007, 59, 1413-1433.
75. Atala, A.; Lanza, R.; Nerem, R.; Thomson, J.A. Principles of Regenerative Medicine, 2nd ed.; Academic Press: London, UK, 2011; pp. 733-1105.
76. Prakash, S.; Khan, A.; Paul, A. Nanoscaffold based stem cell regeneration therapy: Recent advancement and future potential. Expert Opin. Biol. Ther. 2010, 10, 1649-1661.